Prot# BV301 / 00-C-0050K: Randomized Trial of Patient-Specific Vaccination with Conjugated Follicular Lymphoma-Derived Idiotype (FNHLId1) with Local GM-CSF in First Complete Remission (NCI Prot #92)

Project: Research project

Project Details

StatusFinished
Effective start/end date8/27/04 → 12/1/14

Funding

  • PPD Development (BV301 / 00-C-0050K // BV301 / 00-C-0050K)
  • BioVest International, Inc. (BV301 / 00-C-0050K // BV301 / 00-C-0050K)